Larimar Therapeutics, Inc. SEC filings LRMR

Larimar Therapeutics, Inc. has 696 filings in SEC EDGAR's recent list, going back to Aug 28, 2006. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on December 31.

Larimar Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Sep 29, 2026 Sep 29, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations, Other events
Aug 4, 2026 Aug 4, 2026
8-K Current report
Other events
Jun 29, 2026 Jun 29, 2026
8-K Current report
Shareholder vote results
May 19, 2026 May 19, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations, Other events
May 14, 2026 May 14, 2026
ARS Annual report to shareholders Apr 20, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 20, 2026 Apr 17, 2026
PRE 14A Preliminary proxy statement Apr 10, 2026 May 19, 2026
S-8 Employee stock plan registration Mar 19, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
8-K Current report
Other events
Mar 9, 2026 Mar 9, 2026
8-K Current report
Material agreement
Feb 27, 2026 Feb 25, 2026
424B5 Prospectus supplement Feb 26, 2026 —
424B5 Prospectus supplement Feb 25, 2026 —
8-K Current report
Other events
Feb 24, 2026 Feb 24, 2026
8-K Current report
Unregistered share sale, Bylaw or fiscal year change
Jan 22, 2026 Jan 21, 2026
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Unregistered share sale, Bylaw or fiscal year change
Dec 17, 2025 Dec 16, 2025
8-K Current report
Other events
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Other events
Oct 14, 2025 Oct 14, 2025
8-K Current report
Other events
Sep 29, 2025 Sep 29, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Aug 14, 2025 Aug 14, 2025
8-K Current report
Material agreement
Jul 31, 2025 Jul 29, 2025
424B5 Prospectus supplement Jul 31, 2025 —
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
424B5 Prospectus supplement Jul 29, 2025 —
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
8-K Current report
Other events
Jun 23, 2025 Jun 23, 2025
8-K Current report
Shareholder vote results
May 13, 2025 May 13, 2025
8-K Current report
Other events
May 5, 2025 May 5, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations
Apr 30, 2025 Apr 30, 2025
ARS Annual report to shareholders Apr 11, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 11, 2025 Apr 9, 2025
S-8 Employee stock plan registration Mar 24, 2025 —
10-K Annual report Mar 24, 2025 Dec 31, 2024
8-K Current report
Results of operations, Other events
Mar 24, 2025 Mar 24, 2025
8-K Current report
Officer or director change
Jan 27, 2025 Jan 22, 2025
8-K Current report
Other events
Jan 10, 2025 Jan 10, 2025
8-K Current report
Other events
Dec 16, 2024 Dec 16, 2024
8-K Current report
Other events
Nov 18, 2024 Nov 18, 2024
10-Q Quarterly report Oct 30, 2024 Sep 30, 2024
8-K Current report
Results of operations, Other events
Oct 30, 2024 Oct 30, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations, Other events
Aug 7, 2024 Aug 7, 2024
8-K Current report
Other events
Jun 10, 2024 Jun 10, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 29, 2024
8-K Current report
Other events
May 30, 2024 May 30, 2024
EFFECT Filing May 24, 2024 —
CORRESP Letter to the SEC May 22, 2024 —
8-K Current report
Other events
May 20, 2024 May 20, 2024
UPLOAD Letter from the SEC May 16, 2024 —
S-3 Shelf registration May 9, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations, Other events
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 29, 2024 May 29, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 May 29, 2024
S-8 Employee stock plan registration Mar 14, 2024 —
S-8 Employee stock plan registration Mar 14, 2024 —
10-K Annual report Mar 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 14, 2024 Mar 14, 2024
8-K Current report
Other events
Mar 11, 2024 Mar 11, 2024
8-K Current report
Material agreement
Feb 16, 2024 Feb 14, 2024
424B5 Prospectus supplement Feb 14, 2024 —
8-K Current report
Agreement ended
Feb 14, 2024 Feb 13, 2024
424B5 Prospectus supplement Feb 13, 2024 —
8-K Current report
Results of operations, Other events
Feb 12, 2024 Feb 12, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations, Other events
Nov 14, 2023 Nov 14, 2023
8-K Current report
Officer or director change
Oct 3, 2023 Oct 3, 2023
8-K Current report
Other events
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Other events
Jul 25, 2023 Jul 25, 2023
8-K Current report
Other events
Jul 17, 2023 Jul 17, 2023
8-K Current report
Other events
Jun 1, 2023 Jun 1, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations, Other events
May 15, 2023 May 15, 2023
8-K Current report
Shareholder vote results
May 12, 2023 May 9, 2023
ARS Annual report to shareholders Apr 11, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 11, 2023 May 9, 2023
8-K Current report
Officer or director change
Apr 6, 2023 Apr 3, 2023
S-8 Employee stock plan registration Mar 14, 2023 —
S-8 Employee stock plan registration Mar 14, 2023 —
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Results of operations, Other events
Mar 14, 2023 Mar 14, 2023
8-K Current report
Other events
Feb 7, 2023 Feb 7, 2023
8-K Current report
Other events
Jan 9, 2023 Jan 9, 2023
EFFECT Filing Nov 21, 2022 —
CORRESP Letter to the SEC Nov 18, 2022 —
UPLOAD Letter from the SEC Nov 16, 2022 —
S-3 Shelf registration Nov 10, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations, Other events
Nov 10, 2022 Nov 10, 2022
8-K Current report
Other events
Oct 20, 2022 Oct 20, 2022
8-K Current report
Material agreement, Other events
Sep 14, 2022 Sep 14, 2022
424B5 Prospectus supplement Sep 14, 2022 —
8-K Current report
Other events
Sep 14, 2022 Sep 14, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations, Other events
Aug 11, 2022 Aug 11, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 12, 2022 May 10, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations, Other events
May 12, 2022 May 12, 2022
DEF 14A Proxy statement Apr 12, 2022 May 10, 2022
8-K Current report
Officer or director change
Apr 11, 2022 Apr 6, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021
8-K Current report
Results of operations, Other events
Mar 25, 2022 Mar 25, 2022
8-K Current report
Results of operations, Other events
Feb 28, 2022 Feb 28, 2022
8-K Current report
Other events
Feb 14, 2022 Feb 14, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Results of operations, Other events
Nov 12, 2021 Nov 12, 2021
8-K Current report
Results of operations, Other events
Aug 12, 2021 Aug 12, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Other events
Jul 1, 2021 Jul 1, 2021
8-K Current report
Other events
Jun 14, 2021 Jun 14, 2021
8-K Current report
Agreement ended, Other events
May 26, 2021 May 25, 2021
8-K Current report
Material agreement, Unregistered share sale
May 21, 2021 May 21, 2021
8-K Current report
Other events
May 21, 2021 May 20, 2021
8-K Current report
Other events
May 18, 2021 May 18, 2021
8-K Current report
Shareholder vote results
May 17, 2021 May 12, 2021
8-K Current report
Other events
May 11, 2021 May 11, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
DEF 14A Proxy statement Apr 14, 2021 May 12, 2021
8-K/A Amended current report Mar 4, 2021 May 28, 2020
10-K Annual report Mar 4, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 4, 2021 Mar 4, 2021
8-K Current report
Regulation FD disclosure, Other events
Dec 8, 2020 Dec 8, 2020
8-K/A Amended current report Nov 12, 2020 May 28, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2020 Nov 10, 2020
8-K Current report
Material agreement
Oct 30, 2020 Oct 27, 2020
S-8 Employee stock plan registration Oct 2, 2020 —
8-K/A Amended current report
Officer or director change, Shareholder vote results
Sep 29, 2020 Sep 29, 2020
8-K Current report
Officer or director change, Shareholder vote results
Sep 29, 2020 Sep 29, 2020
EFFECT Filing Sep 1, 2020 —
CORRESP Letter to the SEC Aug 31, 2020 —
UPLOAD Letter from the SEC Aug 24, 2020 —
DEFA14A Additional proxy material Aug 19, 2020 —
DEF 14A Proxy statement Aug 19, 2020 Sep 29, 2020
S-3 Shelf registration Aug 14, 2020 —
8-K/A Amended current report Aug 14, 2020 May 28, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2020 Aug 11, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 6, 2020 Jul 31, 2020
EFFECT Filing Jul 14, 2020 —
CORRESP Letter to the SEC Jul 13, 2020 —
UPLOAD Letter from the SEC Jul 10, 2020 —
S-3 Shelf registration Jun 26, 2020 —
S-8 Employee stock plan registration Jun 26, 2020 —
8-K/A Amended current report
Other events
Jun 26, 2020 May 28, 2020
D Filing Jun 10, 2020 —
D Filing Jun 10, 2020 —
8-K Current report
Regulation FD disclosure
Jun 3, 2020 Jun 3, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 2, 2020 May 28, 2020
DEFA14A Additional proxy material May 19, 2020 —
10-Q Quarterly report May 7, 2020 Mar 31, 2020
UPLOAD Letter from the SEC Apr 30, 2020 —
DEFM14A Filing Apr 29, 2020 —
CORRESP Letter to the SEC Apr 27, 2020 —
PRER14A Filing Apr 27, 2020 —
8-K Current report
Listing notice
Apr 24, 2020 Apr 21, 2020
UPLOAD Letter from the SEC Apr 24, 2020 —
CORRESP Letter to the SEC Apr 10, 2020 —
PRER14A Filing Apr 10, 2020 —
UPLOAD Letter from the SEC Apr 6, 2020 —
8-K Current report
Material agreement
Mar 9, 2020 Mar 6, 2020
DEFA14A Additional proxy material Mar 9, 2020 —
PREM14A Filing Mar 6, 2020 Mar 6, 2020
S-8 Employee stock plan registration Mar 5, 2020 —
10-K Annual report Mar 5, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 5, 2020 Mar 5, 2020
DEFA14A Additional proxy material Feb 5, 2020 —
8-K Current report
Regulation FD disclosure
Feb 5, 2020 Feb 5, 2020
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2020 Jan 9, 2020
DEFA14A Additional proxy material Jan 13, 2020 —
DEFA14A Additional proxy material Dec 18, 2019 —
8-K Current report
Material agreement, Unregistered share sale, Change in control, Other events
Dec 18, 2019 Dec 17, 2019
DEFA14A Additional proxy material Dec 18, 2019 —
S-8 Employee stock plan registration Nov 7, 2019 —
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
8-K Current report
Listing notice
Sep 19, 2019 Sep 17, 2019
8-K Current report
Exit or restructuring costs, Officer or director change
Sep 12, 2019 Sep 10, 2019
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Shareholder vote results
Jun 13, 2019 Jun 13, 2019
8-K Current report
Regulation FD disclosure
May 30, 2019 May 30, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEF 14A Proxy statement Apr 26, 2019 Jun 13, 2019
8-K Current report
Other events
Apr 4, 2019 Apr 2, 2019
S-8 Employee stock plan registration Mar 14, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LRMR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bala Cynwyd, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1374690
Former names
ZAFGEN, INC. (until May 19, 2020); ZAFGEN INC (until Nov 3, 2008)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.